Shaoliang Sun

Lanzhou University, Kao-lan-hsien, Gansu Sheng, China

Are you Shaoliang Sun?

Claim your profile

Publications (4)7.54 Total impact

  • [Show abstract] [Hide abstract]
    ABSTRACT: Since the first laparoscopic cholecystectomy was reported, the four-trocar laparoscope has become the golden standard procedure. Some surgeons, however, thought that the three-port technique may be safe, effective, and economic. Our meta-analysis compared the three-port technique to the four-port technique. We searched the Cochrane Library, MEDLINE, EMBASE, and Chinese Biomedical Literature Database. Quality assessment and data extraction were done by two reviewers independently. The statistical analysis was performed by RevMan4.2.10 software. A total of five publications comprising 591 patients met the inclusion criteria. The result showed that three-port technique could not reduce the analgesia requirements: the sample mean difference (SMD) and 95% confidence interval (CI) were -0.28 (-0.66, 0.10). There were no significant differences between the two groups in terms of operating time [weighted mean difference (WMD) = 2.08, 95% CI (-3.63, 7.79)], success rate [odds ratio (OR) = 0.99,95% CI (0.31, 3.12)], or postoperative hospital stay [OR = -0.52,95% CI (-1.22, 0.17)]. The current evidence showed that the two groups had similar operating times, success rates, analgesia requirements, and postoperative hospital stays. The methodological qualities of studies are not high, so more high-quality studies are needed for further analysis.
    World Journal of Surgery 08/2009; 33(9):1904-8. · 2.23 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Several studies have suggested that proton pump inhibitors are efficacious in preventing rebleeding when administered immediately after endoscopic treatments. However, there are limited clinical outcome data on the use of intravenous pantoprazole. To evaluate the efficacy of intravenous pantoprazole after successful endoscopic treatment for peptic ulcer bleeding using evidence from randomized controlled trials (RCTs). The Cochrane Library, MEDLINE, EMBASE and several Chinese databases up to July 2008 were searched. RCTs that compared the relative effectiveness of intravenous pantoprazole with placebo, H2 receptor antagonist or other agents for patients with peptic ulcer bleeding who were pretreated with successful endoscopic therapies were retrieved. Five RCTs comprising a total of 821 participants were included in the final meta-analysis. Overall, there were significant differences in ulcer rebleeding (RR 0.31; 95% CI 0.18 to 0.53; pooled rates were 4.7% for pantoprazole and 15.0% for control), surgical intervention (RR 0.28, 95% CI 0.09 to 0.83; pooled rates were 1.4% in pantoprazole group versus 6.5% in control) and total length of hospital stay (weighted mean difference -1.53; 95% CI -1.91 to -1.16), but not on mortality (RR 0.72, 95% CI 0.29 to 1.81; pooled mortality rates were 1.9% for pantoprazole versus 2.8% for control) and blood transfusion requirements (weighted mean difference -0.53; 95% CI for random effects -1.04 to -0.02) when compared with control treatments. A series of subgroup analyses supported the results from the main analysis. Intravenous administration of pantoprazole after endoscopic therapy for peptic ulcer bleeding reduces rates of ulcer rebleeding, surgical intervention and overall duration of hospital stay, but not mortality and blood transfusion requirements compared with placebo, H2 receptor antagonist or somatostatin.
    Canadian journal of gastroenterology = Journal canadien de gastroenterologie 05/2009; 23(4):287-99. · 1.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This study focuses on probiotics in patients with severe acute pancreatitis. It assesses whether enteral feeding with probiotics use reduces infected necrosis and death in severe acute pancreatitis. We searched the Cochrane Library, Medline, Embase, and Chinese Biomedicine Database. Quality assessment and data extraction were done by two reviewers independently. The statistical analysis was performed by RevMan4.2.10 software. The result was expressed with odds ratio (OR) for the categorical variable. Four studies were included. The result showed that using probiotics could not reduce the risk of infection pancreatic necrosis (OR = 0.56, 95% CI [0.13, 2.35]). There is no significant difference between the two groups in mortality (OR = 0.83, 95% CI [0.14, 4.83]), the mean duration of hospital (WMD = -1.20, 95% CI [-13.13, 10.92]) and the required operation (OR = 0.59, 95% CI [0.11, 3.07]). The present study showed the enteral feeding with probiotic could not reduce the infected necrosis and mortality. Future large-scale, high-quality, placebo-controlled, double-blind trials are needed.
    Langenbeck s Archives of Surgery 01/2009; 394(1):171-7. · 1.89 Impact Factor
  • Kehu Yang, Shaoliang Sun, Jinhui Tian
    Langenbeck s Archives of Surgery 11/2008; · 1.89 Impact Factor